Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia

NCT03695315 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03695315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03695315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
October 31, 2018
Completion date
December 31, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxia, insulin resistance, obstructive sleep apnea